Ontogenic aspects of liver and kidney catechol-O-methyltransferase sensitivity to tolcapone

British Journal of Pharmacology

Volumn 117, Issue 3, 1996, Pages 516-520

  Vieira Coelho, M A ^a   Soares Da Silva, P ^a  

^a Inst of Pharmacol and Therapeutics   (Portugal)

Author keywords

Catechol O methyltransferase; Kidney; Liver; Ontogeny; Tolcapone

Indexed keywords

ADRENALIN; BUFFER; CATECHOL METHYLTRANSFERASE; EGTAZIC ACID; MAGNESIUM CHLORIDE; METADRENALIN; PARGYLINE; S ADENOSYLMETHIONINE; TOLCAPONE;

AGING; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG SENSITIVITY; ENZYME ACTIVITY; ENZYME INHIBITION; KIDNEY HOMOGENATE; LIVER HOMOGENATE; MALE; METHYLATION; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; RAT;

EID: 0030040182     PISSN: 00071188     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1476-5381.1996.tb15220.x     Document Type: Article

References (24)

1. APPRILE, J. & MALAMUD, D. (1975). Catechol-O-methyltransferase in mouse liver plasma membranes Biochem. Biophys. Res. Commun., 64, 1293-1302.
2. AXELROD, J. (1966). Methylation reactions in the formation and metabolism of catecholamines and other biogenic amines. Pharmacol Rev., 18, 995-113.
3. AXELROD, J., ALBERTS, W. & CLEMENTE C. (1959). Distribution of catechol-O-methyltransferase in the nervous system and other tissues. J. Neurochem., 5, 68-71.
4. AXELROD, J. & TOMCHICK, R. (1958). Enzymatic O-methylation of epinephrine and other catechols. J. Biol. Chem., 233, 702-705.
5. BRADEORD, M.M. (1976). A rapid method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem., 72, 248-254.
6. FERNANDES, M.H. & SOARES-DA-SILVA, P. (1993). Sequential involvement of monoamine oxidase and catechol-O-methyltransferase in the metabolism of newly-formed dopamine in rat renal tissues. In Cardiovascular and Renal Actions of Dopamine. ed. Soares-da-Silva P. Adv. Biosci., Vol 88, pp. 21-30. Oxford: Pergamon Press.
7. GULDBERG, H.C. & MARSDEN, C.A. (1975). Catechol-O-methyltransferase: pharmacological aspects. Pharmacol. Rev., 27, 135-206.
8. KOPIN, I.J. (1986). Catecholamine metabolism: basic aspects and clinical significance. Pharmacol. Rev., 37, 334-364.
9. LEE, M.R. (1993). Dopamine and the kidney: ten years on. Clin. Sci., 84, 357-75.
10. MÄNNISTÖ, P.T. & KAAKKOLA, S. (1989). New selective COMT inhibitors: useful adjuncts for Parkinson's disease? Trends Pharmacol. Sci., 10, 54-56.
11. MEISTER, B., BEAN, AJ. & APERIA, A. (1993). Catechol-O-methyltransferase mRNA in the kidney and its appearance during ontogeny. Kidney Int., 44, 726-733.
12. MOTULSKY, H.G., SPANNARD, P. & NEUBIG, R. (1994). GraphPad Prims (Version 1.0). San Diego, U.S.A.: GraphPad Prism Software Inc.
13. ROBERTS, J.W., CORA-LOCATELLI, G., BRAVI, D., METMAN, L.V., MOURADIAN, M.M. & CHASE, T.N. (1993). Catechol-O-methyltransferase (COMT) inhibitor Ro 40-7592 prolongs duration of action of levodopa/carbidopa in parkinson patients. Neurology, 43, (4, Suppl. 2): Abst 684S.
14. ROTH, J.A. (1992). Membrane-bound catechol-O-methyltransferase: A reevaluation of its role in the O-methylation of the catecholamine neurotransmitters. Rev. Physiol. Biochem. Pharmacol., 88, 1-29.
15. SOARES-DA-SILVA, P. (1994). Source and handling of renal dopamine: its physiological importance. News Physiol. Sci., 9, 128-134.
16. SOARES-DA-SILVA, P., FERNANDES, M.H. & PINTO-DO-Ó, P.C. (1993). Cell inward transport of L-DOPA and 3-O-methyl-L-DOPA in rat renal tubules. Br. J. Pharmacol., 112, 611-615.
17. SOARES-DA-SILVA, P. & VIEIRA-COELHO, M.A. (1993). Increased sensitivity of renal catechol-O-methyltransferase to inhibition by tolcapone. J. Am. Soc. Nephrol., 4, 896.
18. TONG, J. & D'IORIO, A. (1977). Solubilization and partial purification of participate catechol-O-methyltransferase from rat liver. Can. J. Biochem., 55, 1108-1113.
19. TRENDELENBURG, U. (1988). The extraneuronal uptake and metabolism of catecholamines. In Catecholamines, ed. Trendelenburg, U. & Weiner, N. Handbook oj Experimental Pharmacology, Vol 90/I, pp. 279-320. Berlin: Springer-Verlag.
20. VIDGREN, J., SVENSSON, L.A. & LILJAS, A. (1994). Crystal structure of catechol-O-methyltransferase. Nature, 368, 354-358.
21. VIEIRA-COELHO, M.A. & SOARES-DA-SILVA, P. (1994). Sensitivity of liver and kidney catechol-O-methyltransferase to inhibition by tolcapone in developing rats. Br. J. Pharmacol., 112, 410P.
22. VIEIRA-COELHO, M.A., FERNANDES, M.H. & SOARES-DA-SILVA, P. (1994). In vivo effects of the monoamine oxidase inhibitors Ro 41-1049 and Ro 19-6327 on the production and fate of renal dopamine. J. Neural Trans. [Suppl] 41, 365-370.
23. ZÜRCHER, G., COLZI, A, & DA PRADA, M. (1990a). Ro 40-7592: inhibition of COMT in rat brain and extracerebral tissues. N. Neural Transm. [Suppl] 32, 375-380.
24. ZÜRCHER, G., KELLER, H.H., KETLER, R., BORGULYA, J., BONETTI, E.P., EIGENMANN, R, & DA PRADA, M. (1990b). Ro 40-7592, a novel, very potent and orally active inhibitor of catechol-O-methyltransferase: a pharmacological study in rats. Adv. Neurol., 53, 497-503.